Dr. Dreyer is an internationally recognized expert in the use of real-world evidence for regulatory purposes. She has experience in building patient registries and patient-generated health datasets through her senior executive leadership roles at IQVIA, Outcome Sciences (acquired by Quintiles) and Epidemiology Resources Inc (acquired by United Health). Dr. Dreyer holds a Ph.D. in epidemiology and Master of Public Health from the University of North Carolina, Chapel Hill.
Dr. Iyasu has more than 35 years of experience in using real-world data for decision making. He held senior roles in epidemiology as the Global Head of Epidemiology at Merck, and Director of the Office of Epidemiology and Pharmacovigilance in the Center for Drug Evaluation and Research at the U.S. Food and Drug Administration. Dr. Iyasu holds an M.D. in medicine from the University of Delhi, Maulana Azad Medical School, and a Master of Public Health from Johns Hopkins University.
Jeremy Brody is a senior consultant with broad experience in healthcare-focused strategy and development of real-world evidence. He held Chief Strategy Officer roles at both Aetion and Kantar Health, in addition to a variety of roles in life sciences-focused private equity and health data companies. Brody holds a B.A. in Psychology from New York University as well as a M.S. in Health Policy and Management from Harvard T.H. Chan School of Public Health.
We’re a a mix of doctors, patients, data nerds, engineers, and builders with one common goal: to make medical data live up to its potential to change the future of health.Open positions